Catalyst Pharmaceuticals, Inc.

NASDAQ:CPRX

20.22 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Operating Activities:
Net Income 71.4183.07939.48274.98331.875-34.004-18.412-18.072-20.233-15.509-12.155-4.076-6.391-4.006-7.242-10.565-4.139-2.729-1.805-0.54
Depreciation & Amortization 33.1431.2390.1920.8850.2980.0380.0460.0430.0340.0270.0220.0110.0430.0260.030.0330.0160.0050.0010
Deferred Income Tax -17.8184.9379.316-32.9710000-1.650-0.176-1.470-0.45-0.601-0.718-0.556-1.22100
Stock Based Compensation 14.257.9076.0736.2613.8253.5512.4081.8361.5850.7780.1760.340.4170.450.6010.7180.5561.22100
Change In Working Capital -37.32413.7295.022-4.111-1.0964.712.029-0.8840.6630.7690.19-0.2850.627-0.227-1.0731.554-0.8580.3250.1760.014
Accounts Receivables -43.075-3.82-0.6324.55-10.537000000000000000
Inventory -4.7391.065-3.219-2.694-1.901-0.05600000000000000
Accounts Payables 10.821.207-1.4880.1391.780.3921.012-0.861-0.020.963-0.5151.1020.158-0.144-0.0830.113-0.2280.3800
Other Working Capital -0.3315.27710.361-6.1059.5624.3751.017-0.0230.683-0.1950.705-1.3870.469-0.083-0.991.441-0.629-0.05500
Other Non Cash Items 79.9395.1560.287-0.012-0.2913.6830.187-0.8861.5850.9942.0660.340.320.450.6010.7180.5561.2211.1730.295
Operating Cash Flow 143.6116.04760.37245.03534.611-25.704-13.743-17.964-18.015-12.942-9.876-5.14-4.985-3.757-7.683-8.26-4.425-1.179-0.455-0.231
Investing Activities:
Investments In Property Plant And Equipment -198.524-0.029-1.021-0.011-0.019-0.0920-0.096-0.023-0.057-0.009-0.052-0.004-0.003-0.002-0.001-0.066-0.021-0.004-0.002
Acquisitions Net 01005-37.244000.0230.02300000000000
Purchases Of Investments -13.465-10-10-10-34.725-36.802-0.004-0.069-0.002-8.684-7.487-14.00700000000
Sales Maturities Of Investments 019.2380571.96921.36803.7170.01900000000000
Other Investing Activites -81.513-10-10-537.244-14.991-0.004-0.023-0.023-8.684-7.487-14.00700000000
Investing Cash Flow -293.5029.209-11.021-5.01137.225-15.526-0.0043.553-0.006-8.741-7.497-14.06-0.004-0.003-0.002-0.001-0.066-0.021-0.004-0.002
Financing Activities:
Debt Repayment 00000000000000000000
Common Stock Issued 2.7929.5694.0990.7581.1160.29853.7730.0834.87426.72514.0729.5655.5431.4563.6984.088020.8631.0470
Common Stock Repurchased -0.982-7.137-12.242-0.0560-0.0040-0.0110000000-0.0030000
Dividends Paid 00000000000000000000
Other Financing Activities -9.8758.8314.099-01.1160.2933.5780.082.2861.8394.1075.016000-0.00303.22500
Financing Cash Flow -10.8571.694-8.1430.7021.1160.29357.350.06937.1628.56418.17814.5815.5431.4563.6984.084020.8631.0470
Other Information:
Effect Of Forex Changes On Cash 00000000000000000000
Net Change In Cash -160.759126.9541.20840.72572.952-40.93743.604-14.34219.1386.8810.806-4.6190.554-2.304-3.987-4.177-4.49119.6640.587-0.232
Cash At End Of Period 137.636298.395171.445130.23789.51216.55957.49713.89328.2359.0972.2161.416.0295.4757.77911.76715.94420.4350.7710.184